28 Oct 2020 --- US-based Cymbiotika has launched a high-dose magnesium l-threonate supplement in liquid format, which is touted for increased bioavailability. The launch addresses widespread magnesium deficiency. Cymbiotika estimates that 65 percent of adults in the US don’t have enough of the electrolyte, which is required for over 300 processes within the human body.
.jpg)
